News
Weight loss drugs Ozempic and Wegovy would no longer be covered by California’s health insurance for low-income people under ...
From 2015 and 2021, almost 30% of deaths among residents and fellows were due to suicide. In other news: Medicare fraud at UnitedHealth; patient fall rates at rehab facilities; and more.
Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...
17h
Zacks Investment Research on MSNSepterna Stock Surges on Oral Obesity Drug Deal With Novo NordiskShares of Septerna SEPN surged 51% on May 14 after the company entered into an exclusive global collaboration and license ...
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...
18h
MarketBeat on MSNIs It Time to Buy the Dip in Novo Nordisk Stock?CompanyOverview|NYSE:NVO] Despite a double beat in its quarterly earnings on May 7, Novo Nordisk A/S (NYSE: NVO) stock is ...
A global trial reveals tirzepatide helps people lose more weight faster than semaglutide. This breakthrough could change ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results